Direct oral anticoagulant use and risk of severe COVID-19.

B Flam Viktor Wintzell Jonas F Ludvigsson Johan Mårtensson Björn Pasternak

Published in: Journal of internal medicine (2020)

Ongoing DOAC use was not associated with reduced risk of severe COVID-19, indicating that prognosis would not be modified by early outpatient DOAC initiation.

Keyphrases

coronavirus disease
sars cov
direct oral anticoagulants
venous thromboembolism
early onset
atrial fibrillation
respiratory syndrome coronavirus
drug induced